Quality Issues Prompt Safety Guidelines for Compounded Drug Pharmacies

Citing persistent quality issues at compounding facilities since a deadly 2012 national fungal meningitis outbreak, the FDA issued final guidance to help prevent contamination of compounded drug products.
Source: JAMA - Category: General Medicine Source Type: research